---
schema_version: "secwatch.filing_event.v1"
accession: "0001600620-24-000087"
form_type: "8-K"
ticker: "AUPH"
cik: "0001600620"
company_name: "Aurinia Pharmaceuticals Inc."
filed_at: "2024-06-14T23:59:59+00:00"
generated_at: "2026-06-01T04:19:56.702635+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Aurinia shareholders reject say-on-pay, equity plan; four directors face conditional resignations

## Summary
- CEO Peter Greenleaf and three other directors received less than majority support; conditional resignations submitted under Majority Voting Policy.
- Say-on-pay vote failed: 30.8M for, 45.3M against, 0.5M abstain.
- Equity Incentive Plan amendment not approved: 35.7M for, 40.5M against.
- PricewaterhouseCoopers ratified as auditor with 85.6M for, 8.1M against.
- Board will decide on the four directors' resignations within 90 days per policy.

## SEC filing metadata
- accession: 0001600620-24-000087
- form_type: 8-K
- ticker: AUPH
- cik: 0001600620
- company_name: Aurinia Pharmaceuticals Inc.
- filed_at: 2024-06-14T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1600620/000160062024000087/0001600620-24-000087-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1600620/000160062024000087/auph-20240614.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001600620-24-000087
- JSON: https://secwatch.observer/filing/0001600620-24-000087.json
- Plain text: https://secwatch.observer/filing/0001600620-24-000087.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.